%0 Letter
%T DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
%A Kizhakeyil A
%A Zaini NBM
%A Poh ZS
%A Wong BHS
%A Loh X
%A Ng AS
%A Low ZS
%A Prasannan P
%A Gong C
%A Tan MGK
%A Nagarajan C
%A Huang D
%A Lu PW
%A Lim JQ
%A Barrans S
%A Ong CK
%A Lim ST
%A Chng WJ
%A Follows G
%A Hodson DJ
%A Du MQ
%A Goh YT
%A Tan SH
%A Grigoropoulos NF
%A Verma NK
%J Mol Cancer
%V 20
%N 1
%D 10 2021 16
%M 34654425
%F 41.444
%R 10.1186/s12943-021-01437-0
%X